| | | | | |
ChemoCentryx Falls on Weak Diabetic Nephropathy Drug Data Tue, 10 Sep, 2013 09:10 AM PDT MOUNTAIN VIEW, Calif. (TheStreet) -- An experimental ChemoCentryx drug designed to treat kidney damage caused by diabetes doesn't appear to be working very well, according to an interim analysis of an mid-stage study announced Tuesday. ChemoCentryx intends to continue the diabetic nephropathy drug stud... Continue reading | | | |
| | | |
| | Drs. Oz and Roizen July 15 Tue, 10 Sep, 2013 08:02 AM PDT Inflammation interferes with your body's ability to use blood sugar for fuel — raising glucose levels to dangerous heights. If you've already been diagnosed with diabetes, gum disease makes it more difficult to get your blood sugar down into a normal range, raising your risk for complications like athe... Continue reading | | |
| |
No comments:
Post a Comment